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HIV prevalence among medical  
students in Johannesburg, South Africa
To the Editor: As part of a study to determine Mycobacterium 
tuberculosis infection rates among medical students in 
Johannesburg, South Africa, we conducted tuberculin skin 
testing (TST) as well as HIV counselling and testing (in order to 
interpret TST results). We offered participation to 190 5th-year 
medical students; only 74 (39%) participated and none were 
HIV infected. The mean age of the participants was 23.9 years 
(median 23 years) and 55% were female.
In two studies on HIV prevalence in South African health 
care workers1,2 the HIV testing was anonymous and unlinked, 
i.e. participants could not learn their HIV status. We offered 
pre- and post-test HIV counselling and all participating 
students elected to receive their HIV results. While both 
studies included health care workers, neither included medical 
students.
Shisana et al. used cluster methods to sample a representative 
5% of all health care workers in South Africa.1 Most (595 out of 
721, or 82.5%) eligible health workers participated; 349 (59%) 
were professional health care workers (physicians and nurses) 
and 246 (41%) were non-professional (N=246) health care 
workers (ward attendants and cleaners). The HIV prevalence 
rate was 20.3% among non-professional workers and 13.7% 
among health professionals. HIV prevalence was higher among 
the 18 - 35-year-olds (20%) than among the 36 - 45-year-olds 
(16.6%). The HIV prevalence rate was not listed separately for 
different categories of professional health care workers. 
Connelly et al. determined the HIV prevalence among 
doctors, nurses, and student nurses at two hospitals in 
Gauteng province, South Africa.2 While they achieved a high 
overall response rate (1 493/1 813, or 82.3%), almost all (98.5%) 
student nurses but few (25%) physicians participated. The 
HIV prevalence rate was 11.5% overall (student nurses 13.8%, 
nurses 13.7%, physicians 2%). HIV prevalence was low in 
hospital workers in the age groups over 55 years (2%) and 
18 - 24 years (6.7%), and higher (10.2 - 15.9%) in all other age 
groups.
The low participation rate among medical students in our 
study (39%) was higher than the 25% participation rate among 
physicians in the study by Connelly et al.,2 even though HIV 
testing in our study was not anonymous. We expected to find 
an HIV prevalence rate among medical students similar to the 
estimated 9%3 to 11.9%4 for Gauteng youth aged 15 - 24 years. 
The lower rate among physicians in the study by Connelly 
et al.2 and in our study among medical students may suggest 
that physicians and medical students are truly at lower risk 
compared with the general population and other health 
workers, or may be a biased estimate result, with only those at 
lowest risk choosing to participate. 
These observations raise several questions. Why do 
physicians and medical students refrain from participation in 
these studies? Is the HIV prevalence among physicians and 
medical students truly lower than in the general population 
and other health workers? Does the low participation rate 
among physicians and medical students, who are well aware of 
the HIV epidemic and the need for all South Africans to know 
their HIV status, indicate that it may be difficult to achieve 
high uptake rates of HIV testing strategies in the general 
population?
It is important to explore these questions further. 
We acknowledge permission to conduct the study by the 
University of the Witwatersrand’s School of Health Sciences, 
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by the RHRU staff and participating medical students. The study 
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National Institute for Occupational Safety and Health (NIOSH).
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Blood alternative products: Correction 
regarding Jehovah’s Witnesses
To the Editor: You published a gross inaccuracy in the 
SAMJ1 by stating that Hemopure has the ‘Thumbs up from 
Jehovah’s Witnesses’. With regard to bovine and human-
derived haemoglobin-based oxygen carriers (HBOCs) you 
BRIEWE
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also incorrectly stated that both ‘Hemopure … and another 
similar product, Polyheme … are unconditionally accepted by 
Jehovah’s Witnesses’. These statements are very misleading to 
readers who may treat our members who endeavour to follow 
the Bible injunction to ‘abstain from … blood’ (Acts 15:20). 
First of all, it is not our policy to endorse any medical 
product. Secondly, the decision as to whether an individual 
Witness will accept or reject fractions from red blood cells, such 
as Hemopure or Polyheme, is a personal one and will vary 
from one Witness patient to another.
The manager of the American Biopure Corporation in 
South Africa, Dr Mandisa Mholwana, is aware of our stand 
on this matter, which was communicated to her in writing 
in early 2008, and she agreed to delete any statement in 
their publications and website to the effect that Hemopure is 
acceptable to Jehovah’s Witnesses. It is regrettable that she did 
not inform you of our clearly stated viewpoint on this.
Considering the importance of the underlying personal, 
medical and constitutional issues in connection with an 
individual’s decision whether to accept Hemopure, we are sure 
that you would wish to correct any impression given in the 
article that we, as Jehovah’s Witnesses, unconditionally accept 
such commercial products.  
C F Muller
Chairman, Christian Congregation of Jehovah’s Witnesses of South Africa
fmuller@jw.org.za
1.    Bateman C. Metanalysis critical of blood alternative product challenged. S Afr Med J 2008; 98: 
746-748.
Chris Bateman replies: I apologise for what seems to have 
been a misunderstanding of the claims made by the Hemopure 
designers and distributors during my interview with them, 
but more especially for not having contacted you to verify 
and clarify. The intention was to convey that the product, 
unlike human blood, was acceptable to Jehovah’s Witnesses, a 
contention I accepted in good faith.
One of the key Hemopure designers quoted in the article, 
Professor Colin Mackenzie, has read your objections. He 
acknowledges that Jehovah’s Witness patients abstain from 
blood, noting also that many Jehovah Witnesses do accept 
HBOCs. Professor Mackenzie adds: ‘the author is correct, 
the decision to accept HBOCs is an individual decision. The 
Jehovah’s Witness religious movement does not and never has 
endorsed any medical product such as HBOCs.’
Professor Mackenzie has apologised for the confusion about 
the church stance that arose during the interview, as has Dr 
Mahlowana for any inference that Hemopure is acceptable 
to all Jehovah’s Witness patients. We hope that publication 
of your letter and this response will help better inform our 
readers.
February 2009, Vol. 99, No. 2  SAMJ
THE SOUTH AFRICAN MEDICAL ASSOCIATION: SECRETARY-GENERAL
Applications are invited for the appointment of a Secretary-General for the South 
African Medical Association.
 
The Secretary-General will provide leadership and oversight regarding the strategic direction 
of the South African Medical Association, working closely with the Board of Directors. The 
Secretary-General will be responsible and accountable for the efficient management and 
administration of the Secretariat.
The appointment is for a 3-year period with the possibility of renewal.
Applications with a covering letter and detailed CV to:  
Ms Dudu Mashinini, Head: Human Resources
Email: dudum@samedical.org
Fax: 012 481 2106
Tel: 012 481 2004
 
Closing date for applications: 28 February 2009  
